EMEA-000500-PIP01-08-M03
Key facts
Active substance |
|
Therapeutic area |
Vaccines
|
Decision number |
P/0035/2015
|
PIP number |
EMEA-000500-PIP01-08-M03
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Prevention of infectious diseases caused by Corynebacterium diphtheriae / Clostridium tetani / Bordetella pertussis / Poliovirus types 1, 2 and 3
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
GSK Vaccines S.r.l.
Tel. +1 438 899 8201 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000500-PIP01-08-M03
|
Compliance opinion date |
27/05/2016
|
Compliance outcome |
positive
|